868PSafety of new androgen receptor inhibitors (ARi) in...

868PSafety of new androgen receptor inhibitors (ARi) in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC): A network meta-analysis of randomized controlled trials (RCT)

Altavilla, A, Maio, M Di, Tucci, M, Lolli, C, Schepisi, G, Buttigliero, C, Vignani, F, Giorgi, U De
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz248.025
Date:
October, 2019
File:
PDF, 78 KB
2019
Conversion to is in progress
Conversion to is failed